Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Disease area: Airway diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Nefedova, L. Sokolova, E. Shmelev (Moscow, Russian Federation). Inhalation antibacterial therapy of COPD acute exacerbation. Eur Respir J 2009; 34: Suppl. 53, 2344

Member's Comments

No comment yet.

Related content which might interest you: An analysis of non-effective empiric antibacterial therapy in COPD acute exacerbation Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections Year: 2007 Combined nebulization therapy in acute asthma exacerbation Source: Eur Respir J 2001; 18: Suppl. 33, 47s Year: 2001 Antibiotics in acute exacerbation of asthma and COPD Source: Eur Respir Monogr 2017; 75: 150-158 Year: 2017 Utility of aerosolized budesonide therapy in acute moderate exacerbations of asthma Source: Eur Respir J 2003; 22: Suppl. 45, 283s Year: 2003 Efficacy and safety of various antimicrobial regimens in the treatment of acute exacerbations of chronic bronchitis Source: Annual Congress 2007 - Infectious lung and pleural diseases Year: 2007 Efficacy of inhaled heparin is effective in the treatment of acute exacerbation of asthma Source: Annual Congress 2007 - New drugs for asthma Year: 2007 N-acetylcysteine for the treatment of acute exacerbations of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 374s Year: 2002 Microorganisms resistant to conventional antimicrobial treatment in acute exacerbation of COPD Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes Year: 2017 The role of nebulised budesonide in the treatment of acute exacerbations of COPD Source: Eur Respir J 2007; 30: 399-400 Year: 2007 Aerosolized budesonide therapy in acute moderate exacerbations of Indian asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 343s Year: 2004 Clinical effectiveness of nebulized budesonide in the treatment of acute asthma and exacerbations of chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 146s Year: 2001 The efficacy and safety of inhaled fluimucil-antibiotic-IT in the treatment of exacerbations of COPD and chronic bronchitis with bronchiectasis Source: Annual Congress 2013 –COPD diagnosis Year: 2013 Speed of recovery after antibiotic treatment of acute exacerbations of moderate to severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 592s Year: 2002 Duration of systemic corticosteroids treatment in COPD exacerbations Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 Acute exacerbation of bronchiectasis and the impact on the duration of antibiotic therapy Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 Association of COPD inhaled  medication adherence with hospitalization for acute exacerbation of COPD (AECOPD) Source: International Congress 2017 – COPD management Year: 2017 Inhaled corticosteroids and hospitalisation due to exacerbation of COPD Source: Eur Respir J 2003; 22: 286-289 Year: 2003 Mechanism by which inhaled bronchodilators prevent exacerbations in chronic obstructive pulmonary disease Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics Year: 2013 Pharmacologic treatment of exacerbations of COPD Source: International Congress 2016 – Management of COPD exacerbations: A European Respiratory Society/American Thoracic Society (ERS/ATS) guideline Year: 2016